Unlock instant, AI-driven research and patent intelligence for your innovation.

Adamantane tetrazole derivative and preparation method and application thereof

A technology of alkyl compounds, applied in the field of drugs for the treatment of diabetes, can solve problems such as undiscovered weight gain

Active Publication Date: 2015-04-01
蚌埠市鼎荣科技信息咨询有限公司
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Clinical results show that this type of drug has a good hypoglycemic effect, and no adverse reactions such as weight gain and hypoglycemia, which are common in other diabetes drugs, have been found

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Adamantane tetrazole derivative and preparation method and application thereof
  • Adamantane tetrazole derivative and preparation method and application thereof
  • Adamantane tetrazole derivative and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024]

[0025] 1.79g (10mmol) of compound II-1 and 3.04g (30mmol) of triethylamine were dissolved in 20mL of dry dichloromethane, stirred under cooling in an ice-water bath, and then slowly added dropwise 2.42g (12mmol) of compound III dissolved in 5mL of dry solution made in dichloromethane. After the addition was complete, the reaction mixture was stirred at room temperature for 1 hour. The reaction mixture was poured into 200 mL of ice water, stirred, extracted with 50 mL×3 dichloromethane, the combined extracts were washed with saline, dried over anhydrous sodium sulfate, and then evaporated to dryness on a rotary evaporator, and the obtained residue was purified by column chromatography , the pure product of IV-1 was obtained, white solid, ESI-MS, m / z=299 and 301 ([M+H] + ).

[0026] 1.80 g (6 mmol) of compound IV-1, 0.68 g (6 mmol) of compound V, 1.00 g (6 mmol) of solid potassium iodide and 4.15 g (30 mmol) of solid potassium carbonate were stirred in 20 mL of dry...

Embodiment 2-5

[0029] Using the same method as in Example 1, the following compounds could be prepared.

[0030]

Embodiment 6

[0031] Embodiment 6 compound is measured to the inhibitory action of DPP-IV enzyme

[0032] Using the fluorescent DPP4 activity detection kit of BPS Bioscience Company, the inhibitory activity of the compound of the present invention on DPP-IV enzyme was determined.

[0033] Dilute the samples successively according to the concentration of 5, 10, 30, 100 and 200ng / kg, and add the samples in the following table in the fluorescence reaction 96-well plate:

[0034]

[0035] Place in a water bath at 22°C for 10 minutes, use a Spectra Max M5 fluorescence detector with an excitation light of 350nm, and measure the absorbance with 450nm fluorescence. Calculation of IC from the concentration-fluorescence intensity curve 50 values, the results are shown in the table below:

[0036] IC of compounds for inhibition of DPP-IV enzymes 50 value

[0037]

[0038] It can be seen from the above table that the compound of the present invention has a strong inhibitory effect on DPP-IV e...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of medicine related to diabetes, in particular to a dipeptidyl peptidase-IV inhibitor which has a general formula I and includes an adamantane tetrazole structure, a preparation method of the dipeptidyl peptidase-IV inhibitor, and the application of the dipeptidyl peptidase-IV inhibitor and the preparation method in preparing diabetes medicine. Please see the formula in the specification, wherein R1 is selected from an alkyl group of H and C1-C5 and a naphthenic base of C3-C5.

Description

technical field [0001] The invention relates to the field of medicine related to diabetes. Specifically, the present invention relates to a dipeptidyl peptidase-IV inhibitor containing an adamantane tetrazole structure, a preparation method thereof, a pharmaceutical composition containing them and a medicine for treating diabetes. Background technique [0002] According to statistics, there were approximately 250 million diabetic patients in the world in 2007, most of whom were type II (ie, non-insulin-dependent) diabetic patients. The antidiabetic drugs currently in clinical use mainly include sulfonylureas, metformin and insulin drugs. In recent years, insulin sensitizers and α-glucosidase inhibitors have also been marketed. These drugs have good therapeutic effects, but severe side effects such as hypoglycemia are common, and there are safety problems in long-term treatment, such as liver toxicity and weight gain. [0003] Dipeptidyl peptidase IV (dipeptidyl peptidase I...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D403/06A61P3/10
CPCC07D403/06
Inventor 蔡子洋
Owner 蚌埠市鼎荣科技信息咨询有限公司